Stay updated with breaking news from Mark Augusti. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BILLERICA, Mass., May 08, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial
Operator: Good afternoon, and welcome to the Fourth Quarter and Full Year 2022 Earnings Conference Call for Conformis, Inc. My name is Josh, and I will be your conference operator today.
Conformis (Nasdaq:CFMS) today announced the first procedure performed with its new Actera hip system for hip reconstruction.
Conformis (Nasdaq:CFMS) today announced the full commercial launch of its new made-to-measure Imprint knee system.
Conformis (NSDQ:CFMS) today posted third-quarter results that missed the earnings consensus on Wall Street but beat revenue estimates.